We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VR
1076
DELISTED
Validus Hold Ltd
VR
| $4.44M | 0.01% |
78,775
+4,513
| +6% | +$257K |
|
1077
Allegiant Air
ALGT
$2.64B
| $4.44M | 0.01% |
27,705
+7,258
| +35% | +$1.22M |
|
1078
Genworth Financial
GNW
$3.78B
| $4.43M | 0.01% |
1,076,219
+33,168
| +3% | +$128K |
|
1079
Lithia Motors
LAD
$8.52B
| $4.43M | 0.01% |
51,680
+13,787
| +36% | +$1.34M |
|
|
ALEX
1080
DELISTED
Alexander & Baldwin
ALEX
| $4.42M | 0.01% |
99,321
+2,609
| +3% | +$116K |
|
1081
EPAM Systems
EPAM
$5.52B
| $4.42M | 0.01% |
58,525
+1,424
| +2% | +$99.1K |
|
|
NUAN
1082
DELISTED
Nuance Communications, Inc.
NUAN
| $4.41M | 0.01% |
294,258
+12,607
| +4% | +$179K |
|
1083
Dave & Buster's
PLAY
$379M
| $4.4M | 0.01% |
72,053
+21,580
| +43% | +$1.23M |
|
1084
Southern Copper
SCCO
$141B
| $4.4M | 0.01% |
132,259
+4,304
| +3% | +$146K |
|
1085
John Wiley & Sons Class A
WLY
$2.63B
| $4.38M | 0.01% |
81,514
+3,032
| +4% | +$165K |
|
|
CIM
1086
Chimera Investment
CIM
$1.04B
| $4.38M | 0.01% |
72,282
+1,623
| +2% | +$90.4K |
|
1087
Trex
TREX
$4.51B
| $4.38M | 0.01% |
252,252
+66,632
| +36% | +$1.15M |
|
1088
Outfront Media
OUT
$5.59B
| $4.37M | 0.01% |
167,388
+17,100
| +11% | +$447K |
|
1089
RLJ Lodging Trust
RLJ
$1.88B
| $4.36M | 0.01% |
185,258
+11,376
| +7% | +$265K |
|
1090
Quaker Houghton
KWR
$2.84B
| $4.35M | 0.01% |
33,073
+13,278
| +67% | +$1.74M |
|
1091
Madison Square Garden
MSGS
$9.5B
| $4.35M | 0.01% |
30,565
+1,748
| +6% | +$228K |
|
1092
Semtech
SMTC
$10.8B
| $4.35M | 0.01% |
128,690
+36,779
| +40% | +$1.23M |
|
1093
SM Energy
SM
$7.62B
| $4.35M | 0.01% |
180,912
-2,379
| -1% | -$65.9K |
|
1094
Simpson Manufacturing
SSD
$7.67B
| $4.34M | 0.01% |
100,680
+25,705
| +34% | +$1.11M |
|
|
HI
1095
DELISTED
Hillenbrand
HI
| $4.32M | 0.01% |
120,567
+34,427
| +40% | +$1.27M |
|
1096
Haemonetics
HAE
$3.81B
| $4.31M | 0.01% |
106,271
+25,945
| +32% | +$1.01M |
|
1097
Churchill Downs
CHDN
$5.86B
| $4.3M | 0.01% |
162,552
+6,222
| +4% | +$155K |
|
1098
Howard Hughes
HHH
$3.8B
| $4.3M | 0.01% |
38,497
+2,016
| +6% | +$217K |
|
|
WBMD
1099
DELISTED
WebMD Health Corp.
WBMD
| $4.29M | 0.01% |
81,472
+154
| +0.2% | +$7.87K |
|
|
LSXMA
1100
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $4.28M | 0.01% |
152,304
+5,093
| +3% | +$138K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.